Eli Lilly, a renowned drug manufacturer, stated that its GLP-1 pill, orforglipron, assisted individuals in reducing 12.4% of their weight following 72 weeks in a late-stage study.The company ...

Stocks are rising on Wall Street, even as President Donald Trump’s latest tariffs kicked into effect on dozens of countries.

Malcolm Hoyland was arrested in a police bust in Prestwich after he made 17 cocaine drops for the notorious Byrne Organised ...

At the same time, Trump's hint of a carveout for coming duties on semiconductors boosted tech for a second consecutive day.

A trial assessing a new daily pill for weight loss has shown that people taking the drug can shed kilos in weeks, potentially ...

Eli Lilly shares plunged 12% in morning trading Thursday after reporting less-than-stellar results of a new study of an experimental anti-obesity pill that is expected to become a blockbuster.The pill ...

After teasing another collaboration with Noctua during Computex earlier this year, ASUS has officially launched its GeForce ...

Lilly’s orforglipron cut body weight as expected in the Phase III ATTAIN-1 trial, but to a lesser extent than rival Novo ...

Bloomberg journalists discuss today's biggest winners and losers in the stock market. Listen for analysis on the companies ...

Shock’ as study reveals how weight-loss pill stacks up against injections - Shares in a pharmaceutical company plummeted ...

Lilly's daily obesity pill, orforglipron, shows positive results in late-stage trial, with patients losing nearly 12% of body ...

For comparison, Lilly's arch-rival in the weight-loss category, Novo Nordisk, is developing an oral formulation of ...